GUERINI ROCCO, ELENA
GUERINI ROCCO, ELENA
Dipartimento di Oncologia ed Emato-Oncologia
Clinicopathological characteristics of multiple-classifier endometrial cancers: a cohort study and systematic review
2024 L. Antonio De Vitis, G. Schivardi, G. Caruso, C. Fumagalli, D. Vacirca, M. Teresa Achilarre, A. Aloisi, A. Garbi, V. Zanagnolo, G. Aletti, E. Guerini-Rocco, A. Mariani, A. Maggioni, M. Barberis, G. Bogani, N. Colombo, F. Multinu, I. Betella
In-house homologous recombination deficiency testing in ovarian cancer: A multi-institutional Italian pilot study
2023 F. Pepe, E. Guerini-Rocco, M. Fassan, N. Fusco, D. Vacirca, A. Ranghiero, K. Venetis, A. Rappa, S.V. Taormina, G. Russo, E. Rebellato, G. Munari, A. Moreno-Manuel, C. De Angelis, C. Zamagni, G. Valabrega, U. Malapelle, G. Troncone, M. Barberis, A. Iaccarino
Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey
2023 N. Fusco, M. Ivanova, C. Frascarelli, C. Criscitiello, B. Cerbelli, M. Gemma Pignataro, A. Pernazza, E. Sajjadi, K. Venetis, G. Cursano, F. Pagni, C. Di Bella, M. Accardo, M. Amato, P. Amico, C. Bartoli, G. Bogina, L. Bortesi, R. Boldorini, S. Bruno, D. Cabibi, P. Caruana, E. Dainese, E. De Camilli, V. Dell’Anna, L. Duda, C. Emmanuele, G. Nicolò Fanelli, B. Fernandes, G. Ferrara, L. Gnetti, A. Gurrera, G. Leone, R. Lucci, C. Mancini, G. Marangi, M.G. Mastropasqua, L. Nibid, S. Orrù, M. Pastena, M. Peresi, L. Perracchio, A. Santoro, V. Vezzosi, C. Zambelli, V. Zuccalà, A. Rizzo, L. Costarelli, F. Pietribiasi, A. Santinelli, C. Scatena, G. Curigliano, E. Guerini-Rocco, M. Martini, P. Graziano, I. Castellano, G. D'Amati
Trop-2 as an Actionable Biomarker in Breast Cancer
2023 G. Cursano, E. Frigo, E. Sajjadi, M. Ivanova, K. Venetis, E. Guerini-Rocco, C. Criscitiello, G. Curigliano, N. Fusco
Advances in Early Breast Cancer Risk Profiling: From Histopathology to Molecular Technologies
2023 C. Pescia, E. Guerini-Rocco, G. Viale, N. Fusco
Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management
2023 M. Ivanova, F.M. Porta, F. Giugliano, C. Frascarelli, E. Sajjadi, K. Venetis, G. Cursano, G. Mazzarol, E. GUERINI ROCCO, G. Curigliano, C. Criscitiello, N. Fusco
Revolutionizing Cancer Research: The Impact of Artificial Intelligence in Digital Biobanking
2023 C. Frascarelli, G. Bonizzi, C. Rosella Musico, E. Mane, C. Cassi, E. GUERINI ROCCO, A. Farina, A. Scarpa, R. Lawlor, L. Reggiani Bonetti, S. Caramaschi, A. Eccher, S. Marletta, N. Fusco
Germline pathogenic variants in metaplastic breast cancer patients and the emerging role of the BRCA1 gene
2023 G. Corso, M. Marabelli, M. Calvello, S. Gandini, M. Risti, I. Feroce, S. Mannucci, A. Girardi, A.M. De Scalzi, F. Magnoni, E. Marino, L. Bernard, P. Veronesi, E. Guerini-Rocco, M. Barberis, A. Guerrieri-Gonzaga, B. Bonanni
Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial
2022 F. Conforti, P.A. Zucali, L. Pala, C. Catania, V. Bagnardi, I. Sala, P. Della Vigna, M. Perrino, P. Zagami, C. Corti, S. Stucchi, M. Barberis, E. Guerini-Rocco, B. Di Venosa, F. De Vincenzo, N. Cordua, A. Santoro, G. Giaccone, T.M. De Pas
Breast Cancer during Pregnancy as a Special Type of Early-Onset Breast Cancer: Analysis of the Tumor Immune Microenvironment and Risk Profiles
2022 E. Sajjadi, K. Venetis, M. Noale, H.A. Azim, C. Blundo, G. Bonizzi, E. Di Loreto, G. Scarfone, S. Ferrero, S. Maggi, M. Barberis, P. Veronesi, V.E. Galimberti, G. Viale, N. Fusco, F.A. Peccatori, E. Guerini-Rocco
Osteoclast-like stromal giant cells in breast cancer likely belong to the spectrum of immunosuppressive tumor-associated macrophages
2022 E. Sajjadi, G. Gaudioso, A. Terrasi, F. Boggio, K. Venetis, M. Ivanova, L. Bertolasi, G. Lopez, L. Runza, A. Premoli, D. Lorenzini, E. Guerini-Rocco, S. Ferrero, V. Vaira, N. Fusco
Role and evaluation of pathologic response in early breast cancer specimens after neoadjuvant therapy: consensus statement
2022 E. Guerini-Rocco, G. Botti, M.P. Foschini, C. Marchio, M.G. Mastropasqua, G. Perrone, E. Roz, A. Santinelli, I. Sassi, V. Galimberti, L. Gianni, G. Viale
Low-risk triple-negative breast cancers: Clinico-pathological and molecular features
2022 N. Fusco, E. Sajjadi, K. Venetis, M. Ivanova, S. Andaloro, E. Guerini-Rocco, E. Montagna, P. Caldarella, P. Veronesi, M. Colleoni, G. Viale
Standard operating procedures for biobank in oncology
2022 G. Bonizzi, L. Zattoni, M. Capra, C. Cassi, G. Taliento, M. Ivanova, E. Guerini-Rocco, M. Fumagalli, M. Monturano, A. Albini, G. Viale, R. Orecchia, N. Fusco
HER2 in Metastatic Colorectal Cancer: Pathology, Somatic Alterations, and Perspectives for Novel Therapeutic Schemes
2022 M. Ivanova, K. Venetis, E. GUERINI ROCCO, L. Bottiglieri, M. Giuseppe Mastropasqua, O. Garrone, N. Fusco, M. Ghidini
HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer
2022 K. Venetis, E. Crimini, E. Sajjadi, C. Corti, E. Guerini-Rocco, G. Viale, G. Curigliano, C. Criscitiello, N. Fusco
Outcome of patients with metastatic triple negative breast cancer treated with first-line chemotherapy: a single institution retrospective analysis
2022 N. Bianco, M. Milano, E. Pagan, C. Oriecuia, V. Bagnardi, E.G. Rocco, G.I. Santomauro, G. Peruzzotti, M. Colleoni, G. Viale
Hotspot ESR1 mutations are multimodal and contextual modulators of breast cancer metastasis
2022 L. Zheqi, W. Yang, M.E. Yates, N. Tasdemir, A. Bahreini, J. Chen, K.M. Levine, N.M. Priedigkeit, A. Nasrazadani, S. Ali, L. Buluwela, S. Arnesen, J. Gertz, J.K. Richer, B. Troness, D. El-Ashry, Q. Zhang, L. Gerratana, Y. Zhang, M. Cristofanilli, M.A. Montanez, P. Sundd, C.T. Wallace, S.C. Watkins, C. Fumagalli, E. Guerini-Rocco, L. Zhu, G.C. Tseng, N. Wagle, J.S. Carroll, P. Jank, C. Denkert, M.M. Karsten, J. Blohmer, B.H. Park, P.C. Lucas, J.M. Atkinson, A.V. Lee, S. Oesterreich
Mismatch repair-deficient hormone receptor-positive breast cancers : Biology and pathological characterization
2021 E. Sajjadi, K. Venetis, R. Piciotti, M. Invernizzi, E. Guerini-Rocco, S. Haricharan, N. Fusco
Making the most of complexity to create opportunities: Comprehensive genomic profiling and molecular tumor board for patients with non-small cell lung cancer (NSCLC)
2021 C. Fumagalli, E. Guerini-Rocco, M. Barberis